Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome.

Shao B, Wahrenbrock MG, Yao L, David T, Coughlin SR, Xia L, Varki A, McEver RP.

Blood. 2011 Oct 13;118(15):4015-23. doi: 10.1182/blood-2011-07-368514. Epub 2011 Aug 22.

2.
3.
4.

Neutrophil cathepsin G modulates platelet P-selectin expression and inhibits P-selectin-mediated platelet-neutrophil adhesion.

Ilton MK, Taylor ML, Misso NL, Thompson PJ, Hung J.

Clin Sci (Lond). 1998 Apr;94(4):437-45.

PMID:
9640350
5.
6.

CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells.

Aigner S, Sthoeger ZM, Fogel M, Weber E, Zarn J, Ruppert M, Zeller Y, Vestweber D, Stahel R, Sammar M, Altevogt P.

Blood. 1997 May 1;89(9):3385-95.

7.
8.

Role of P-selectin, beta2-integrins, and Src tyrosine kinases in mouse neutrophil-platelet adhesion.

Evangelista V, Manarini S, Coller BS, Smyth SS.

J Thromb Haemost. 2003 May;1(5):1048-54.

9.
10.

Tyrosine replacement in P-selectin glycoprotein ligand-1 affects distinct kinetic and mechanical properties of bonds with P- and L-selectin.

Ramachandran V, Nollert MU, Qiu H, Liu WJ, Cummings RD, Zhu C, McEver RP.

Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13771-6.

11.
13.

Human neutrophil cathepsin G is a potent platelet activator.

LaRosa CA, Rohrer MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD.

J Vasc Surg. 1994 Feb;19(2):306-18; discussion 318-9.

PMID:
7509416
14.

Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers protein-tyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule.

Evangelista V, Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A, Totani L, Piccardoni P, Vestweber D, de Gaetano G, Cerletti C.

Blood. 1999 Feb 1;93(3):876-85.

15.

P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo.

Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD.

J Exp Med. 2000 Apr 17;191(8):1413-22.

17.

Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis.

Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A.

Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3352-7.

19.

Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice.

Woulfe DS, Lilliendahl JK, August S, Rauova L, Kowalska MA, Abrink M, Pejler G, White JG, Schick BP.

Blood. 2008 Apr 1;111(7):3458-67. Epub 2007 Dec 19.

20.

Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia.

Maugeri N, Malato S, Femia EA, Pugliano M, Campana L, Lunghi F, Rovere-Querini P, Lussana F, Podda G, Cattaneo M, Ciceri F, Manfredi AA.

Blood. 2011 Sep 22;118(12):3359-66. doi: 10.1182/blood-2011-02-337337. Epub 2011 Jun 24.

Supplemental Content

Support Center